Semler Scientific Investors Urged to Act as Oct. 28 Lead-Plaintiff Deadline Nears in DOJ Disclosure Suit
The case centers on allegations that Semler withheld a DOJ False Claims Act inquiry, and a later annual report disclosure was followed by a one‑day stock drop of more than 9%.
Overview
- A securities class action has been filed covering purchasers of Semler Scientific shares from March 10, 2021 through April 15, 2025.
- Plaintiff firms including Rosen, Levi & Korsinsky, and Faruqi & Faruqi are soliciting investors ahead of the October 28, 2025 deadline to seek lead‑plaintiff status.
- The complaint claims Semler failed to disclose a material DOJ investigation and discussed potential False Claims Act exposure only in hypothetical terms.
- Semler’s 2024 Form 10‑K disclosed that initial DOJ settlement talks began and ceased on February 11, 2025, warning of the risk of a DOJ civil complaint.
- Following that disclosure, the stock fell more than 9% on the next trading day, and no class has been certified to date.